The positive association between the atherogenic index of plasma and the risk of new-onset hypertension: a nationwide cohort study in China

References

• Collaboration NCDRF, Carrillo-Larco RM, Danaei G, Riley LM, Paciorek CJ, Stevens GA, Gregg EW, Bennett JE, Solomon B, Singleton RK, et al. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. The Lancet. 2021;398(10304):957–8. doi:10.1016/S0140-6736(21)01330-1.
   PubMed Web of Science ®Google Scholar
• Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS, Boehme AK, Buxton AE, Carson AP, Commodore-Mensah Y, et al. Heart disease and stroke statistics—2022 update: a report from the American heart association. Circulat. 2022;145(8):e153–639. doi:10.1161/CIR.0000000000001052.
   PubMed Web of Science ®Google Scholar
• Wang Z, Chen Z, Zhang L, Wang X, Hao G, Zhang Z, Shao L, Tian Y, Dong Y, Zheng C, et al. Status of hypertension in China: results from the China hypertension survey, 2012-2015. Circulat. 2018;137(22):2344–56. doi:10.1161/CIRCULATIONAHA.117.032380.
   PubMed Web of Science ®Google Scholar
• Qin Z, Zhou K, Li Y, Cheng W, Wang Z, Wang J, Gao F, Yang L, Xu Y, Wu Y, et al. The atherogenic index of plasma plays an important role in predicting the prognosis of type 2 diabetic subjects undergoing percutaneous coronary intervention: results from an observational cohort study in China. Cardiovasc Diabetol. 2020;19(1):23. doi:10.1186/s12933-020-0989-8.
   PubMed Web of Science ®Google Scholar
• Dobiasova M, Frohlich J. The new atherogenic plasma index reflects the triglyceride and HDL-cholesterol ratio, the lipoprotein particle size and the cholesterol esterification rate: changes during lipanor therapy. Vnitr Lek. 2000;46(3):152–56.
   PubMedGoogle Scholar
• Fernandez-Macias JC, Ochoa-Martinez AC, Varela-Silva JA, Perez-Maldonado IN. Atherogenic index of plasma: novel predictive biomarker for cardiovascular illnesses. Arch Med Res. 2019;50:285–94. doi:10.1016/j.arcmed.2019.08.009.
   PubMed Web of Science ®Google Scholar
• Won KB, Jang MH, Park EJ, Park HB, Heo R, Han D, Chang HJ. Atherogenic index of plasma and the risk of advanced subclinical coronary artery disease beyond traditional risk factors: an observational cohort study. Clin Cardiol. 2020;43:1398–404. doi:10.1002/clc.23450.
   PubMed Web of Science ®Google Scholar
• Yuan Y, Hu JW, Wang Y, Wang KK, Zheng WL, Chu C, Ma Q, Yan Y, Liao YY, Mu JJ. Association between atherogenic index of plasma and subclinical renal damage over a 12-year follow-up: Hanzhong adolescent hypertension study. Eur J Clin Nutr. 2020;74(2):278–84. doi:10.1038/s41430-019-0530-x.
   PubMed Web of Science ®Google Scholar
• Fu L, Zhou Y, Sun J, Zhu Z, Xing Z, Zhou S, Wang Y, Tai S. Atherogenic index of plasma is associated with major adverse cardiovascular events in patients with type 2 diabetes mellitus. Cardiovasc Diabetol. 2021;20(1):201. doi:10.1186/s12933-021-01393-5.
   PubMed Web of Science ®Google Scholar
• Ma X, Sun Y, Cheng Y, Shen H, Gao F, Qi J, Yang L, Wang Z, Shi D, Liu Y, et al. Prognostic impact of the atherogenic index of plasma in type 2 diabetes mellitus patients with acute coronary syndrome undergoing percutaneous coronary intervention. Lipids Health Dis. 2020;19(1):240. doi:10.1186/s12944-020-01418-0.
   PubMed Web of Science ®Google Scholar
• Onat A, Can G, Kaya H, Hergenc G. “Atherogenic index of plasma” (log10 triglyceride/high-density lipoprotein−cholesterol) predicts high blood pressure, diabetes, and vascular events. J Clin Lipidol. 2010;4(2):89–98. doi:10.1016/j.jacl.2010.02.005.
   PubMed Web of Science ®Google Scholar
• Tan M, Zhang Y, Jin L, Wang Y, Cui W, Nasifu L, He B. Association between atherogenic index of plasma and prehypertension or hypertension among normoglycemia subjects in a Japan population: a cross-sectional study. Lipids Health Dis. 2023;22(1):87. doi:10.1186/s12944-023-01853-9.
   PubMed Web of Science ®Google Scholar
• Li YW, Kao TW, Chang PK, Chen WL, Wu LW. Atherogenic index of plasma as predictors for metabolic syndrome, hypertension and diabetes mellitus in Taiwan citizens: a 9-year longitudinal study. Sci Rep. 2021;11(1):9900. doi:10.1038/s41598-021-89307-z.
   PubMed Web of Science ®Google Scholar
• Popkin BM, Du S, Zhai F, Zhang B. Cohort profile: the China health and Nutrition Survey--monitoring and understanding socio-economic and health change in China, 1989-2011. Int J Epidemiol. 2010;39(6):1435–40. doi:10.1093/ije/dyp322.
   PubMed Web of Science ®Google Scholar
• Yuan Y, Sun W, Kong X. Comparison between distinct insulin resistance indices in measuring the development of hypertension: the China health and nutrition survey. Front Cardiovasc Med. 2022;9:912197. doi:10.3389/fcvm.2022.912197.
   PubMed Web of Science ®Google Scholar
• Yuan Y, Sun W, Kong X. Relationship between metabolically healthy obesity and the development of hypertension: a nationwide population-based study. Diabetol Metab Syndr. 2022;14(1):150. doi:10.1186/s13098-022-00917-7.
   PubMed Web of Science ®Google Scholar
• Gao H, Wang K, Zhao W, Zhuang J, Jiang Y, Zhang L, Liu Q, Ahmadizar F. Cardiorenal risk profiles among data-driven type 2 diabetes sub-phenotypes: a post-hoc analysis of the China health and nutrition survey. Front Endocrinol (Lausanne). 2022;13:828403. doi:10.3389/fendo.2022.828403.
   PubMed Web of Science ®Google Scholar
• Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, Xu JS, Huang SM, Wang LN, Huang W, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17:2937–44.
   PubMed Web of Science ®Google Scholar
• Yano Y, Fujimoto S, Asahi K, Watanabe T. Prevalence of chronic kidney disease in China. Lancet. 2012;380:213–14. doi:10.1016/S0140-6736(12)61209-4.
   PubMedGoogle Scholar
• Zhou BF. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults--study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci. 2002;15(1):83–96.
   PubMed Web of Science ®Google Scholar
• Chen C, Lu FC. Department of disease control ministry of health PRC: the guidelines for prevention and control of overweight and obesity in Chinese adults. Biomed Environ Sci. 2004;17(18):1–36.
   PubMedGoogle Scholar
• Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. JAMA. 2003;289(19):2560–72. doi:10.1001/jama.289.19.2560.
   PubMed Web of Science ®Google Scholar
• Webster AC, Nagler EV, Morton RL, Masson P. Chronic kidney disease. Lancet. 2017;389(10075):1238–1252. doi:10.1016/S0140-6736(16)32064-5.
   PubMed Web of Science ®Google Scholar
• Diaz A, Tringler M, Wray S, Ramirez AJ, Cabrera Fischer EI. The effects of age on pulse wave velocity in untreated hypertension. J Of Clin Hypertens. 2018;20(2):258–65. doi:10.1111/jch.13167.
   Web of Science ®Google Scholar
• Gao Q, Lin Y, Xu R, Luo F, Chen R, Li P, Zhang Y, Liu J, Deng Z, Li Y, et al. Positive association of triglyceride-glucose index with new-onset hypertension among adults: a national cohort study in China. Cardiovasc Diabetol. 2023;22(1):58. doi:10.1186/s12933-023-01795-7.
   PubMed Web of Science ®Google Scholar
• Whelton PK, Carey RM, Aronow WS, Casey DE Jr., Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, et al. ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American college of cardiology/American heart association task force on clinical practice guidelines. Hypertens. 2017;2018(71):1269–324. doi:10.1161/HYP.0000000000000066.
   Google Scholar
• Thomas SJ, Booth JN 3rd, Dai C, Li X, Allen N, Calhoun D, Carson AP, Gidding S, Lewis CE, Shikany JM, et al. Cumulative incidence of hypertension by 55 years of age in blacks and whites: the CARDIA study. J Am Heart Assoc. 2018;7(14):7. doi:10.1161/JAHA.117.007988.
   Web of Science ®Google Scholar
• Gao J, Sun H, Liang X, Gao M, Zhao H, Qi Y, Wang Y, Liu Y, Li J, Zhu Y, et al. Ideal cardiovascular health behaviors and factors prevent the development of hypertension in prehypertensive subjects. Clin Exp Hypertens. 2015;37:650–55.
   PubMed Web of Science ®Google Scholar
• Kim SH, Cho YK, Kim YJ, Jung CH, Lee WJ, Park JY, Huh JH, Kang JG, Lee SJ, Ihm SH. Association of the atherogenic index of plasma with cardiovascular risk beyond the traditional risk factors: a nationwide population-based cohort study. Cardiovasc Diabetol. 2022;21(1):81. doi:10.1186/s12933-022-01522-8.
   PubMed Web of Science ®Google Scholar
• Lioy B, Webb RJ, Amirabdollahian F. The association between the atherogenic index of plasma and cardiometabolic risk factors: a review. Healthcare (Basel). 2023;11(7):11. doi:10.3390/healthcare11070966.
   Google Scholar
• Alexander RW. Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertens. 1995;25(2):155–61. doi:10.1161/01.hyp.25.2.155.
   PubMed Web of Science ®Google Scholar
• Hosseini SA, Aghamohammadi V, Ashtary-Larky D, Alipour M, Ghanavati M, Lamuchi-Deli N. Are young Iranian women with metabolically healthy obesity at increased risk of CVD incidence? J vasc bras. 2020;19:e20190106. doi:10.1590/1677-5449.190106.
   PubMedGoogle Scholar
• Choudhary MK, Eraranta A, Koskela J, Tikkakoski AJ, Nevalainen PI, Kahonen M, Mustonen J, Porsti I. Atherogenic index of plasma is related to arterial stiffness but not to blood pressure in normotensive and never-treated hypertensive subjects. Blood Press. 2019;28:157–67. doi:10.1080/08037051.2019.1583060.
   PubMed Web of Science ®Google Scholar
• McGill JB, Haffner S, Rees TJ, Sowers JR, Tershakovec AM, Weber M. Progress and controversies: treating obesity and insulin resistance in the context of hypertension. J Clin Hypertens. 2009;11(1):36–41. doi:10.1111/j.1751-7176.2008.00065.x.
   Web of Science ®Google Scholar
• Seravalle G, Grassi G. Obesity and hypertension. Pharmacol Res. 2017;122:1–7. doi:10.1016/j.phrs.2017.05.013.
   PubMed Web of Science ®Google Scholar
• Hall JE, Do Carmo JM, da Silva AA, Wang Z, Hall ME. Obesity, kidney dysfunction and hypertension: mechanistic links. Nat Rev Nephrol. 2019;15(6):367–85. doi:10.1038/s41581-019-0145-4.
   PubMed Web of Science ®Google Scholar
• Morales-Villegas E. Dyslipidemia, hypertension and diabetes metaflammation. A unique mechanism for 3 risk factors. Curr Hypertens Rev. 2014;9(4):278–96. doi:10.2174/1573402110666140702091315.
   Google Scholar
• Sironi AM, Gastaldelli A, Mari A, Ciociaro D, Postano V, Buzzigoli E, Ghione S, Turchi S, Lombardi M, Ferrannini E. Visceral fat in hypertension: influence on insulin resistance and beta-cell function. Hypertens. 2004;44(2):127–33. doi:10.1161/01.HYP.0000137982.10191.0a.
   PubMed Web of Science ®Google Scholar
• Oparil S, Zaman MA, Calhoun DA. Pathogenesis of hypertension. Ann Intern Med. 2003;139(9):761–776. doi:10.7326/0003-4819-139-9-200311040-00011.
   PubMed Web of Science ®Google Scholar
• DeMarco VG, Aroor AR, Sowers JR. The pathophysiology of hypertension in patients with obesity. Nat Rev Endocrinol. 2014;10(6):364–76. doi:10.1038/nrendo.2014.44.
   PubMed Web of Science ®Google Scholar
• Buhler FR, Tkachuk VA, Hahn AWA, Resink TJ. Low- and high-density lipoproteins as hormonal regulators of platelet, vascular endothelial and smooth muscle cell interactions: relevance to hypertension. J Hypertens Suppl. 1991;9:S28–36. doi:10.1097/00004872-199112006-00005.
   PubMedGoogle Scholar
• Galle J, Ochslen M, Schollmeyer P, Wanner C. Oxidized lipoproteins inhibit endothelium-dependent vasodilation. Effects of pressure and high-density lipoprotein. Hypertens. 1994;23(5):556–64. doi:10.1161/01.hyp.23.5.556.
   PubMed Web of Science ®Google Scholar
• Hayakawa H, Raij L. Relationship between hypercholesterolaemia, endothelial dysfunction and hypertension. J Hypertens. 1999;17(5):611–19. doi:10.1097/00004872-199917050-00004.
   PubMed Web of Science ®Google Scholar
• Jonas K, Magon W, Podolec P, Kopec G. Triglyceride-to-high-density lipoprotein cholesterol ratio and systemic inflammation in patients with idiopathic pulmonary arterial hypertension. Med Sci Monit. 2019;25:746–753. doi:10.12659/MSM.912766.
   PubMed Web of Science ®Google Scholar
• Angeli F, Reboldi G, Gentile G, Verdecchia P. The emerging role of high-density lipoprotein cholesterol in hypertension trials. J Hypertens. 2009;27:458–60. doi:10.1097/HJH.0b013e3283232a59.
   PubMed Web of Science ®Google Scholar